查找地点
有关时间、上门服务和预约查找地点
有关时间、上门服务和预约This test includes the following genes: ABCA3, ABCC8, ABCD1, ACADM, ACADVL, ACAT1, AGA, AGXT, AHI1, AIRE, ALDOB, ALPL, ANO10, ARSA, ARX, ASL, ASPA, ATP7B, BBS1, BBS2, BCKDHB, BLM, BTD, CBS, CC2D2A, CCDC88C, CEP290, CFTR, CHRNE, CLCN1, CLRN1, CNGB3, COL7A1, CPT2, CYP11A1, CYP21A2, CYP27A1, CYP27B1, DHCR7, DHDDS, DLD, DMD, DYNC2H1, ELP1, ERCC2, EVC2, F9, FAH, FANCC, FKRP, FKTN, FMO3, FMR1, G6PC1, GAA, GALT, GBA1 (previously known as GBA), GBE1, GJB2, GLA, GNPTAB, GRIP1, HBA1, HBA2, HBB, HEXA, HPS1, HPS3, IDUA, L1CAM, LRP2, MCCC2, MCOLN1, MCPH1, MID1, MLC1, MMACHC, MMUT, MVK, NAGA, NEB, NPHS1, NR0B1, OCA2, OTC, PAH, PCDH15, PKHD1, PLP1, PMM2, POLG, PRF1, RARS2, RNASEH2B, RPGR, RS1, SCO2, SLC19A3, SLC26A2, SLC26A4, SLC37A4, SLC6A8, SMN1, SMPD1, TF, TMEM216, TNXB, TYR, USH2A and XPC.
This test includes the following genes: ABCA3, ABCC8, ABCD1, ACADM, ACADVL, ACAT1, AGA, AGXT, AHI1, AIRE, ALDOB, ALPL, ANO10, ARSA, ARX, ASL, ASPA, ATP7B, BBS1, BBS2, BCKDHB, BLM, BTD, CBS, CC2D2A, CCDC88C, CEP290, CFTR, CHRNE, CLCN1, CLRN1, CNGB3, COL7A1, CPT2, CYP11A1, CYP21A2, CYP27A1, CYP27B1, DHCR7, DHDDS, DLD, DMD, DYNC2H1, ELP1, ERCC2, EVC2, F9, FAH, FANCC, FKRP, FKTN, FMO3, FMR1, G6PC1, GAA, GALT, GBA |
This test includes the following genes: ABCA3, ABCC8, ABCD1, ACADM, ACADVL, ACAT1, AGA, AGXT, AHI1, AIRE, ALDOB, ALPL, ANO10, ARSA, ARX, ASL, ASPA, ATP7B, BBS1, BBS2, BCKDHB, BLM, BTD, CBS, CC2D2A, CCDC88C, CEP290, CFTR, CHRNE, CLCN1, CLRN1, CNGB3, COL7A1, CPT2, CYP11A1, CYP21A2, CYP27A1, CYP27B1, DHCR7, DHDDS, DLD, DMD, DYNC2H1, ELP1, ERCC2, EVC2, F9, FAH, FANCC, FKRP, FKTN, FMO3, FMR1, G6PC1, GAA, GALT, GBA1 (previously known as GBA), GBE1, GJB2, GLA, GNPTAB, GRIP1, HBA1, HBA2, HBB, HEXA, HPS1, HPS3, IDUA, L1CAM, LRP2, MCCC2, MCOLN1, MCPH1, MID1, MLC1, MMACHC, MMUT, MVK, NAGA, NEB, NPHS1, NR0B1, OCA2, OTC, PAH, PCDH15, PKHD1, PLP1, PMM2, POLG, PRF1, RARS2, RNASEH2B, RPGR, RS1, SCO2, SLC19A3, SLC26A2, SLC26A4, SLC37A4, SLC6A8, SMN1, SMPD1, TF, TMEM216, TNXB, TYR, USH2A and XPC. |
Males are not tested for x-linked disorders, including fragile X syndrome.
Test orders must include an attestation that the provider has the patient's informed consent for genetic testing.
14 - 21 days (In some cases, additional time may be required for confirmatory or reflex tests.)
Turnaround time is defined as the usual number of days from the date of pickup of a specimen for testing to when the result is released to the ordering provider. In some cases, additional time should be allowed for additional confirmatory or additional reflex tests. Testing schedules may vary.
For more information, please view the literature below.
Clinical Questionnaire for Inheritest® Carrier Screen and GeneSeq® PLUS
Whole blood or Oragene Dx 500 saliva kit
Whole blood or Oragene Dx 500 saliva kit Whole blood or Oragene Dx 500 saliva kit |
Whole blood or Oragene Dx 500 saliva kit Whole blood or Oragene Dx 500 saliva kit |
8.5 mL whole blood or Oragene Dx saliva kit
8.5 mL whole blood or Oragene Dx saliva kit 8.5 mL whole blood or Oragene Dx saliva kit |
8.5 mL whole blood or Oragene Dx saliva kit 8.5 mL whole blood or Oragene Dx saliva kit |
3 mL whole blood or Oragene Dx saliva kit
Yellow-top (ACD-A) tube or lavender-top (EDTA) tube or Oragene Dx 500 saliva collection kit
Yellow-top (ACD-A) tube or lavender-top (EDTA) tube or Oragene Dx 500 saliva collection kit Yellow-top (ACD-A) tube or lavender-top (EDTA) tube or Oragene Dx 500 saliva collection kit |
Yellow-top (ACD-A) tube or lavender-top (EDTA) tube or Oragene Dx 500 saliva collection kit Yellow-top (ACD-A) tube or lavender-top (EDTA) tube or Oragene Dx 500 saliva collection kit |
Standard phlebotomy; follow Oragene Dx 500 saliva kit collection instructions. Do not eat, drink, smoke or chew gum 30 minutes prior to collection.
Standard phlebotomy; follow Oragene Dx 500 saliva kit collection instructions. Do not eat, drink, smoke or chew gum 30 minutes prior to collection. Standard phlebotomy; follow Oragene Dx 500 saliva kit collection instructions. Do not eat, drink, smoke or chew gum 30 minutes prior to collection. |
Standard phlebotomy; follow Oragene Dx 500 saliva kit collection instructions. Do not eat, drink, smoke or chew gum 30 minutes prior to collection. Standard phlebotomy; follow Oragene Dx 500 saliva kit collection instructions. Do not eat, drink, smoke or chew gum 30 minutes prior to collection. |
Maintain specimen at room temperature or refrigerate at 4°C. Do not freeze.
Whole blood: 4 days at room temperature or 4°C
Saliva: 60 days at room temperature
Whole blood: 4 days at room temperature or 4°C Saliva: 60 days at room temperature Whole blood: 4 days at room temperature or 4°C Saliva: 60 days at room temperature |
Whole blood: 4 days at room temperature or 4°C Saliva: 60 days at room temperature Whole blood: 4 days at room temperature or 4°C Saliva: 60 days at room temperature |
Frozen or hemolyzed specimen; quantity not sufficient for analysis; improper container or blood specimens more than four days post draw
This test is used for pan-ethnic carrier screening and includes 110 of the genes included in the American College of Medical Genetics (ACMG) Tier 3 category.
Technologies used do not detect germline mosaicism and do not rule out the presence of large chromosomal aberrations including rearrangements and gene fusions, or variants in regions or genes not included in this test, or possible inter/intragenic interactions between variants or repeat expansions.
Variant classification and/or interpretation may change over time if more information becomes available. False positive or false negative results may occur for reasons that include: rare genetic variants, sex chromosome abnormalities, pseudogene interference, blood transfusions, bone marrow transplantation, somatic or tissue-specific mosaicism, mislabeled samples or erroneous representation of family relationships.
This test was developed and its performance characteristics determined by Labcorp. It has not been cleared or approved by the Food and Drug Administration.
Next Generation Sequencing: Identifies genetic variants, including small nucleotide variants (SNVs), insertions, deletions and copy number variants (CNVs).
Spinal muscular atrophy (SMA): Copy number assessment of SMN1 exon 7 by quantitative polymerase chain reaction (qPCR). For carrier screening, when two copies of SMN1 are detected, allelic discrimination qPCR targeting c.*3+80T>G in SMN1 is performed. The presence or absence of c.*3+80T>G correlates with an increased or decreased risk, respectively, of being a silent carrier (2+0).
Fragile X syndrome: Polymerase chain reaction (PCR) followed by capillary electrophoresis, with reflex to AGG interruption analysis and methylation PCR analysis for positive samples.
Order Code | Order Code Name | Order Loinc | Result Code | Result Code Name | UofM | Result LOINC |
---|---|---|---|---|---|---|
481816 | Inheritest High Frequency | 481798 | Genes | 48018-6 | ||
481816 | Inheritest High Frequency | 481799 | Ethnicity | 46463-6 | ||
481816 | Inheritest High Frequency | 481800 | Specimen Type | 31208-2 | ||
481816 | Inheritest High Frequency | 481801 | Genetic Counselor | 89993-0 | ||
481816 | Inheritest High Frequency | 481802 | Indication | 42349-1 | ||
481816 | Inheritest High Frequency | 481803 | Result: | 19102-3 | ||
481816 | Inheritest High Frequency | 481804 | Interpretation | 53039-4 | ||
481816 | Inheritest High Frequency | 481805 | General Comments | 8262-8 | ||
481816 | Inheritest High Frequency | 481806 | Recommendations | 62385-0 | ||
481816 | Inheritest High Frequency | 481807 | Additional ClinicalInformation | 55752-0 | ||
481816 | Inheritest High Frequency | 481808 | Comments | 8251-1 | ||
481816 | Inheritest High Frequency | 481809 | Methods/Limitations | 49549-9 | ||
481816 | Inheritest High Frequency | 481810 | References | 75608-0 | ||
481816 | Inheritest High Frequency | 481811 | Disorders Tested | 19102-3 | ||
481816 | Inheritest High Frequency | 481812 | Director Review/Release | 72486-4 | ||
481816 | Inheritest High Frequency | 481813 | 51969-4 | |||
481816 | Inheritest High Frequency | 481815 | Patient Gender | 76691-5 |
Reflex Table for Patient Gender | ||||||
---|---|---|---|---|---|---|
Order Code | Order Name | Result Code | Result Name | UofM | Result LOINC | |
Reflex 1 | 482132 | High Freq/Guideline + FragileX | 482130 | High Freq/Guideline NGSBC | N/A |
Reflex Table for Patient Gender | ||||||
---|---|---|---|---|---|---|
Order Code | Order Name | Result Code | Result Name | UofM | Result LOINC | |
Reflex 1 | 482132 | High Freq/Guideline + FragileX | 482131 | FRAXBC | N/A |
Reflex Table for Patient Gender | ||||||
---|---|---|---|---|---|---|
Order Code | Order Name | Result Code | Result Name | UofM | Result LOINC | |
Reflex 1 | 482133 | High Freq/Guideline NGSBC | 482133 | High Freq/Guideline NGSBC | N/A |
© 2021 Laboratory Corporation of America® Holdings and Lexi-Comp Inc. All Rights Reserved.
CPT Statement/Profile Statement
The LOINC® codes are copyright © 1994-2021, Regenstrief Institute, Inc. and the Logical Observation Identifiers Names and Codes (LOINC) Committee. Permission is granted in perpetuity, without payment of license fees or royalties, to use, copy, or distribute the LOINC® codes for any commercial or non-commercial purpose, subject to the terms under the license agreement found at https://loinc.org/license/. Additional information regarding LOINC® codes can be found at LOINC.org, including the LOINC Manual, which can be downloaded at LOINC.org/downloads/files/LOINCManual.pdf